About: Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1995 (uk) im Jahr 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1995 (ast) artikull shkencor i botuar më 01 janar 1995 (sq) scientific article published on 01 January 1995 (en)
publication date	wds:Q73286072-785BB256-D1E0-4474-8886-58DB9003C53E
publication date	1995-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q73286072-3D7981EB-CA02-4BC2-9523-AC682BDCF31F
exact match	https://scigraph.springernature.com/pub.10.1007/bf01062579
cites work	wds:Q73286072-049D0759-8365-493E-BAC1-4B53FA39BC3D wds:Q73286072-11009695-E9F1-4414-80E7-2439CA9D1F0A wds:Q73286072-18D5C354-649B-4790-9B3B-BB3C12412AA6 wds:Q73286072-2B443B1D-B8A4-4880-907F-E774447C5F5C wds:Q73286072-4C47DB8B-AA63-478E-A4F2-48A4816F6D63 wds:Q73286072-4CD82E8A-0E6E-4148-B781-2BA329F0DF92 wds:Q73286072-594D5777-0888-47B3-8CC2-F939620D7A46 wds:Q73286072-680107DD-87FE-48EA-8C05-42A00831534C wds:Q73286072-777B30B7-552B-4064-929E-B89DBB89C1F8 wds:Q73286072-7C8E3762-74A0-48A0-B365-4B6454A135E7 wds:Q73286072-9FF5104F-F831-47AF-9C9C-0148334D758E wds:Q73286072-A211387D-55C1-4554-9F3A-41B2C441BDC0 wds:Q73286072-AB8C08E7-1653-4C14-8570-398F89D9C81C wds:Q73286072-D14039A9-C581-4205-8610-C084895044E9 wds:Q73286072-D93E3BE4-72DB-4EFB-BA5E-5B15D0C0EDB7 wds:Q73286072-DD0506DA-714B-4FD4-87C1-455F0D07CA28 wds:Q73286072-E2ED2410-901A-4C81-81A0-7D52929EFDFD wds:Q73286072-E8B80C7B-BA20-4985-BDB0-7EE3399D68C4 wds:Q73286072-F208E95E-91FF-459B-938E-216116F4C61F wds:Q73286072-F946809A-A28E-45A6-966B-72BE19FCB959 wds:Q73286072-FCFAD653-B09E-46E6-9C2A-84486FE6D000
cites work	Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in unstable angina pectoris Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs Activated coagulation time of whole blood Importance of adequate heparin dosage in arterial angioplasty in a porcine model Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage A Simple Method of Heparin Management During Prolonged Extracorporeal Circulation Adequate heparinization during PTCA: assessment using activated clotting times Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: temporal relationship to discontinuation of anticoagulation Importance of antithrombin therapy during coronary angioplasty Staining modification of creatine kinase isoenzyme method Progress report: the activated coagulation time of whole blood (ACT) The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding Predictive value of preoperative in vitro and in vivo studies for correct individual heparinization in cardiac surgery Creatine kinase isoenzyme MB: discrepancy between immuno-inhibition and electrophoretic measurement in lyophilized proficiency samples
author name string	wds:Q73286072-011D307C-DB79-49E7-B418-BCAD711E98BE wds:Q73286072-06344A26-C05A-4C0F-B7BF-31DFC0D34C52 wds:Q73286072-5A5A54CC-85C8-46AA-B345-081B23DAAB81 wds:Q73286072-6A22F56C-0CD2-49C2-86DE-3631E03EB23E wds:Q73286072-789FD4FA-AA95-46C7-870A-DFB7D690E267 wds:Q73286072-C5DB5C5C-F54F-42F6-A0B9-DBF1877F150B wds:Q73286072-F8337498-B224-4039-958D-7450D71F32ED
author name string	Becker RC Laifer LI Heller LI Weiner BH Carey KT Greenwald LL Voyce SJ
rdfs:label	Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (en) Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (nl) Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (sq)
skos:prefLabel	Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (en) Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (nl) Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (sq)
name	Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (en) Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (nl) Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (sq)
title	wds:Q73286072-095709C3-D1C8-4DC3-8635-F79699051799
title	Clinical Experience with Routine Activated Coagulation Time Monitoring During Elective PTCA (en)
page(s)	wds:Q73286072-CDD72DCC-8EA5-4371-9E0D-77AB606F8620
page(s)	201-206
instance of	wds:Q73286072-341293DD-2825-4DA6-BB83-2FF8B5F0933F
instance of	scholarly article
PubMed ID	wds:Q73286072-786D8CED-19F4-4104-9767-C0B5C7482EF4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10603531
PubMed ID	10603531
published in	wds:Q73286072-F955537A-F70E-405B-BA46-B6952287AD26
published in	Journal of Thrombosis and Thrombolysis
issue	wds:Q73286072-B9A86D12-AA31-4B74-910E-9BDF84FC2DED
volume	wds:Q73286072-376B29CF-D425-48F6-8E14-15AF6D120B82
issue	2
volume	1
DOI	wds:Q73286072-748600E7-3983-493F-883D-FFEE27859400
DOI	http://dx.doi.org/10.1007/BF01062579
DOI	10.1007/BF01062579
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73286072
is cites work of	Activated clotting time as a screening test prior to catheter-based cardiovascular procedures
is cites work of	wds:Q74600262-7DDEC27B-020C-4516-83D9-3B94D9231E46

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software